secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2023-10-19T23:59:59+00:00
Accession:  0001628280-23-034703
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology annual meeting results: all director nominees elected, auditor ratified, say-on-pay approved
--------------------------------------------------------------------------------

- All seven director nominees elected; Scott Tobin and Philip Breitfeld each received over 9.6M votes for.
- Ratification of EisnerAmper as independent auditor for FY ending April 30, 2024 passed with 10,041,893 votes for.
- Non-binding advisory vote on executive compensation approved with 9,444,385 votes for (257,887 abstentions).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828023034703/0001628280-23-034703-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828023034703/csbr-20231019.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-034703

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer